Figure 3.

Weights for MCDA Value Matrix components and scores for growth hormone for Turner syndrome in Canada (average data from eight panelists). *A five point weighting scale was used with 1 lowest and 5 highest weight. **A short four point scoring scale was used with 0 lowest (to account for component that would not bring any value) and 3 highest score.

Goetghebeur et al. Cost Effectiveness and Resource Allocation 2010 8:4   doi:10.1186/1478-7547-8-4
Download authors' original image